Caroline Baumal

Insider Reports History

Entity
Individual
Location
C/O Apellis Pharmaceuticals, Inc., 100 5 Th Avenue, 3 Rd Floor, Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Caroline Baumal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caroline Baumal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Medical Officer Common Stock 58.4K $3.72M $63.69 Jan 16, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Medical Officer Stock Option (Right to Buy) 37K $2.45M $66.30 Jan 16, 2024 Direct

Insider Reports Filed by Caroline Baumal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 2 $2.45M 4 Jan 17, 2024 Chief Medical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 4, 2024 1 -$165K 4 Jan 5, 2024 Chief Medical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 3, 2023 0 $0 3 Jan 9, 2023 Chief Medical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 3, 2023 2 $2.46M 4 Jan 5, 2023 Chief Medical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 3, 2023 0 $0 3 Jan 5, 2023 Chief Medical Officer